(Q48474982)

11 February 2018

title

The neurotoxin 1-methyl-4-phenylpyridinium is sequestered within neurons that contain the vesicular monoamine transporter (English)

1 reference

11 February 2018

author name string

Speciale SG

1

1 reference

11 February 2018

Liang CL

2

1 reference

11 February 2018

Sonsalla PK

3

1 reference

11 February 2018

Edwards RH

4

1 reference

11 February 2018

German DC

5

1 reference

11 February 2018

language of work or name

English

0 references

publication date

1 June 1998

1 reference

11 February 2018

published in

Neuroscience

1 reference

11 February 2018

volume

84

1 reference

11 February 2018

issue

4

1 reference

11 February 2018

page(s)

1177-1185

1 reference

11 February 2018

Rapid ATP loss caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mouse brain

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900570-8

7 January 2021

Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900570-8

7 January 2021

Quantitative autoradiography of the rat brain vesicular monoamine transporter using the binding of [3H]dihydrotetrabenazine and 7-amino-8-[125I]iodoketanserin

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900570-8

7 January 2021

Characterization of a putatively vesicular binding site for [3H]MPP+ in mouse striatal membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900570-8

7 January 2021

Selective MPP+ uptake into synaptic dopamine vesicles: possible involvement in MPTP neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900570-8

7 January 2021

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian syndrome in Macaca fascicularis: which midbrain dopaminergic neurons are lost?

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900570-8

7 January 2021

Midbrain dopaminergic cell loss in Parkinson's disease and MPTP-induced parkinsonism: sparing of calbindin-D28k-containing cells

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900570-8

7 January 2021

The neurotoxin MPTP causes degeneration of specific nucleus A8, A9 and A10 dopaminergic neurons in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900570-8

7 January 2021

Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900570-8

7 January 2021

Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900570-8

7 January 2021

Selective retention of MPP+ within the monoaminergic systems of the primate brain following MPTP administration: an in vivo autoradiographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900570-8

7 January 2021

1-Methyl-4-phenyl-pyridinium (MPP+) uptake does not explain the differential toxicity of MPP+ in the nigrostriatal and mesolimbic dopaminergic pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900570-8

7 January 2021

The biodisposition of MPP+ in mouse brain

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900570-8

7 January 2021

Selective accumulation of MPP+ in the substantia nigra: a key to neurotoxicity?

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900570-8

7 January 2021

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900570-8

7 January 2021

Extensive sequence divergence between the human and rat brain vesicular monoamine transporter: Possible molecular basis for species differences in the susceptibility to MPP+

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900570-8

7 January 2021

Midbrain dopaminergic neurons in the mouse: co-localization with Calbindin-D28K and calretinin

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900570-8

7 January 2021

Midbrain dopaminergic neurons in the mouse that contain calbindin-D28k exhibit reduced vulnerability to MPTP-induced neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900570-8

7 January 2021

A cDNA that suppresses MPP+ toxicity encodes a vesicular amine transporter

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900570-8

7 January 2021

Autoradiography of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): uptake in the monoaminergic pathways and in melanin containing tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900570-8

7 January 2021

Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900570-8

7 January 2021

Midbrain dopaminergic neurons in the mouse: computer-assisted mapping

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900570-8

7 January 2021

Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900570-8

7 January 2021

Differential expression of two vesicular monoamine transporters

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900570-8

7 January 2021

Astrocytes convert the parkinsonism inducing neurotoxin, MPTP, to its active metabolite, MPP+

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900570-8

7 January 2021

Potentiation by reserpine and tetrabenazine of brain catecholamine depletions by MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) in the mouse; evidence for subcellular sequestration as basis for cellular resistance to the toxicant

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900570-8

7 January 2021

Differences in the reserpine-sensitive storage in vivo of 1-methyl-4-phenylpyridinium in rats and mice may explain differences in catecholamine toxicity to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900570-8

7 January 2021

Histaminergic transmission in the mammalian brain

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900570-8

7 January 2021

The influence of dose and dosing interval on MPTP-induced dopaminergic neurotoxicity in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900570-8

7 January 2021

Studies on the effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on central catecholamine neurons in C57BL/6 mice. Comparison with three other strains of mice

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900570-8

7 January 2021

Stereotaxic mapping of the monoamine pathways in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900570-8

7 January 2021

[3H]methoxytetrabenazine: a high specific activity ligand for estimating monoaminergic neuronal integrity

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900570-8

7 January 2021

In brown Norway rats, MPP+ is accumulated in the nigrostriatal dopaminergic terminals but it is not neurotoxic: a model of natural resistance to MPTP toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900570-8

7 January 2021

10.1016/S0306-4522(97)00570-8

Identifiers

DOI

1 reference

11 February 2018

1 reference

11 February 2018